AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Instadose Pharma Corp.

$0 +$0.00 (+0.00%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
53.19K
AVG Volume
874
Trailing/Forward PE
-0.02/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
00.250.50.75119 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q422 Q1
INSD Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
22 Q10
21 Q40
21 Q30
21 Q20
21 Q10
20 Q40
20 Q30
20 Q20
20 Q10
19 Q40
Net Income (USD) · TTM
-2M-1.5M-1M-500K019 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q422 Q1
INSD Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
22 Q1-1.72M
21 Q4-586.07K
21 Q3-150.16K
21 Q2-88.95K
21 Q1-37.62K
20 Q4-33.97K
20 Q3-28.33K
20 Q2-29.58K
20 Q1-29.24K
19 Q4-29.48K
Operating Income (USD) · TTM
-2M-1.5M-1M-500K019 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q422 Q1
INSD Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
22 Q1-1.7M
21 Q4-586.07K
21 Q3-150.43K
21 Q2-89.22K
21 Q1-37.89K
20 Q4-31.23K
20 Q3-25.32K
20 Q2-24.9K
20 Q1-22.92K
19 Q4-23.27K
EBITDA (USD) · TTM
-15M-10M-5M05M19 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q422 Q1
INSD EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
22 Q1-1.02M
21 Q4-13.18M
21 Q3-12.8M
21 Q2-12.74M
21 Q1-12.71M
20 Q4110.4K
20 Q385.14K
20 Q230.39K
20 Q1-22.77K
19 Q4-23.24K
Cash Flows (USD) · TTM
-50K050K100K150K200K19 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q422 Q1
INSD Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
22 Q1160.4K
21 Q4-81
21 Q3502
21 Q2488
21 Q1473
20 Q4277
20 Q3-331
20 Q2-346
20 Q1-359
19 Q4-164
EPS (USD) · TTM
-0-0-0-0019 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q422 Q1
INSD EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
22 Q1-0
21 Q4-0
21 Q3-0
21 Q2-0
21 Q1-0
20 Q4-0
20 Q3-0
20 Q2-0
20 Q1-0
19 Q4-0
Expenses (USD) · TTM
0500K1M1.5M19 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q422 Q1
INSD Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
22 Q11.24M
21 Q4586.32K
21 Q3150.43K
21 Q289.16K
21 Q137.82K
20 Q434.17K
20 Q329.59K
20 Q230.9K
20 Q130.56K
19 Q430.8K
Shares Outstanding (USD) · TTM
-10M-7.5M-5M-2.5M02.5MBuybacks (Repurchases)Stock-Based Compensation19 Q420 Q120 Q220 Q320 Q421 Q121 Q221 Q321 Q422 Q1
INSD Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
22 Q1-131.42K
21 Q4-9.59M
21 Q3-9.59M
21 Q2-9.59M
21 Q1-9.59M
20 Q40
20 Q30
20 Q20
20 Q10
19 Q40
Free Cash Flow Yield
0%10000%20000%30000%40000%med 27.41%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
INSD Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26301.54%
Sep 26301.54%
Aug 26301.54%
Aug 26301.54%
Aug 26301.54%
Aug 26301.54%
Jul 26301.54%
Jul 26301.54%
Jul 26301.54%
Jul 26301.54%
Jul 26301.54%
Jun 26301.54%
Jun 26301.54%
Jun 26301.54%
Jun 26301.54%
May 26301.54%
May 26301.54%
May 26301.54%
May 26301.54%
May 26301.54%
Apr 26301.54%
Apr 26301.54%
Apr 26301.54%
Apr 26301.54%
Mar 26301.54%
Mar 26301.54%
Mar 26301.54%
Mar 26301.54%
Feb 26301.54%
Feb 26301.54%
Feb 26301.54%
Feb 26301.54%
Jan 26301.54%
Jan 26301.54%
Jan 26301.54%
Jan 26301.54%
Jan 26301.54%
Dec 25301.54%
Dec 25301.54%
Dec 25301.54%
Dec 25301.54%
Nov 25301.54%
Nov 25301.54%
Nov 25301.54%
Nov 25301.54%
Oct 2527.41%
Oct 2527.41%
Oct 2527.41%
Oct 2527.41%
Oct 2527.41%
Sep 2527.41%
Sep 2527.41%
Sep 2527.41%
Sep 2527.41%
Aug 2527.41%
Aug 2527.41%
Aug 2527.41%
Aug 2527.41%
Aug 2527.41%
Jul 2530154.12%
Jul 2527.41%
Jul 2527.41%
Jul 2527.41%
Jun 2527.41%
Jun 2527.41%
Jun 2527.41%
Jun 2527.41%
May 2527.41%
May 2527.41%
May 2527.41%
May 2527.41%
May 2527.41%
Apr 2527.41%
Apr 2527.41%
Apr 2527.41%
Apr 2527.41%
Mar 2527.41%
Mar 2527.41%
Mar 2527.41%
Mar 2527.41%
Feb 2527.41%
Feb 2527.41%
Feb 2527.41%
Feb 2527.41%
Jan 2527.41%
Jan 2527.41%
Jan 2527.41%
Jan 2527.41%
Jan 2527.41%
Dec 2427.41%
Dec 2427.41%
Dec 2427.41%
Dec 2427.41%
Nov 2427.41%
Nov 2427.41%
Nov 2427.41%
Nov 2427.41%
Nov 2427.41%
Oct 2427.41%
Oct 2427.41%
EV/EBITDA
657075808590med 86.77Nov 20Dec 20Jan 21Feb 21Mar 21Apr 21
INSD EV/EBITDA by quarter
PeriodEV/EBITDA
Apr 2166.91
Apr 2166.91
Mar 2166.91
Mar 2166.91
Mar 2166.91
Mar 2166.91
Feb 2166.91
Feb 2186.77
Feb 2186.77
Feb 2186.77
Jan 2186.77
Jan 2186.77
Jan 2186.77
Jan 2186.77
Dec 2086.77
Dec 2086.77
Dec 2086.77
Dec 2086.77
Dec 2086.77
Nov 2086.77
Nov 2086.77
Nov 2086.77
Nov 2086.77
Oct 2086.77
Price/Operating Cashflow
01234med 3.65Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
INSD Price/Operating Cashflow by quarter
PeriodPrice/Operating Cashflow
Sep 260.33
Sep 260.33
Aug 260.33
Aug 260.33
Aug 260.33
Aug 260.33
Jul 260.33
Jul 260.33
Jul 260.33
Jul 260.33
Jul 260.33
Jun 260.33
Jun 260.33
Jun 260.33
Jun 260.33
May 260.33
May 260.33
May 260.33
May 260.33
May 260.33
Apr 260.33
Apr 260.33
Apr 260.33
Apr 260.33
Mar 260.33
Mar 260.33
Mar 260.33
Mar 260.33
Feb 260.33
Feb 260.33
Feb 260.33
Feb 260.33
Jan 260.33
Jan 260.33
Jan 260.33
Jan 260.33
Jan 260.33
Dec 250.33
Dec 250.33
Dec 250.33
Dec 250.33
Nov 250.33
Nov 250.33
Nov 250.33
Nov 250.33
Oct 253.65
Oct 253.65
Oct 253.65
Oct 253.65
Oct 253.65
Sep 253.65
Sep 253.65
Sep 253.65
Sep 253.65
Aug 253.65
Aug 253.65
Aug 253.65
Aug 253.65
Aug 253.65
Jul 250
Jul 253.65
Jul 253.65
Jul 253.65
Jun 253.65
Jun 253.65
Jun 253.65
Jun 253.65
May 253.65
May 253.65
May 253.65
May 253.65
May 253.65
Apr 253.65
Apr 253.65
Apr 253.65
Apr 253.65
Mar 253.65
Mar 253.65
Mar 253.65
Mar 253.65
Feb 253.65
Feb 253.65
Feb 253.65
Feb 253.65
Jan 253.65
Jan 253.65
Jan 253.65
Jan 253.65
Jan 253.65
Dec 243.65
Dec 243.65
Dec 243.65
Dec 243.65
Nov 243.65
Nov 243.65
Nov 243.65
Nov 243.65
Nov 243.65
Oct 243.65
Oct 243.65
Price to Book
00.010.010.010.02med 0.02Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
INSD Price to Book by quarter
PeriodPrice to Book
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250.02
Oct 250.02
Oct 250.02
Oct 250.02
Oct 250.02
Sep 250.02
Sep 250.02
Sep 250.02
Sep 250.02
Aug 250.02
Aug 250.02
Aug 250.02
Aug 250.02
Aug 250.02
Jul 250
Jul 250.02
Jul 250.02
Jul 250.02
Jun 250.02
Jun 250.02
Jun 250.02
Jun 250.02
May 250.02
May 250.02
May 250.02
May 250.02
May 250.02
Apr 250.02
Apr 250.02
Apr 250.02
Apr 250.02
Mar 250.02
Mar 250.02
Mar 250.02
Mar 250.02
Feb 250.02
Feb 250.02
Feb 250.02
Feb 250.02
Jan 250.02
Jan 250.02
Jan 250.02
Jan 250.02
Jan 250.02
Dec 240.02
Dec 240.02
Dec 240.02
Dec 240.02
Nov 240.02
Nov 240.02
Nov 240.02
Nov 240.02
Nov 240.02
Oct 240.02
Oct 240.02
Instadose Pharma Corp.
INSD
Stockpicker

Video analysis: INSD

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.